关于 Adlai nortye biopharma co., ltd.

关于公司

Adlai Nortye is a science-led biopharmaceutical company dedicated to discovering, developing and commercializing new drugs in the field of oncology/immuno-oncology. Their mission is to improve patient lives by developing differentiated, innovative medicines that help people live better and longer. They have 23 patents granted and 7 PCT published. With extensive experience in peptide and protein drugs, they have expanded their expertise into small molecules and therapeutic antibodies. Through close collaboration with global partners, they have successfully positioned theirselves in the fields of immuno-oncology/oncology and have several programs ongoing from early pre-clinical to phase 3 ready.